Sphere Fluidics Files UK Patent on Novel Mass Spectrometry BioChip
Sphere Fluidics has filed another patent on design and use of novel mass spectrometry biochips for processing libraries of picodroplets. “Sphere Fluidics’ technology enables high-throughput, miniaturised mass spectrometry which has novel applications for screening libraries of engineered cells for production of valuable molecules – such as Active Pharmaceutical Ingredients or Industrial Enzymes. These areas are immensely important in the pharmaceutical industry and in the rapidly growing Synthetic Biology market.” said Dr Frank F. Craig (CEO). “The technology also has applications in screening of inhibitors against libraries of enzymes created by e.g. enzyme evolution.” he added.